Clinical outcome and cost-effectiveness of 1-year nutritional intervention program in COPD Source: International Congress 2018 – Nutrition and metabolic syndrome in COPD Year: 2018
Clinical and economic outcomes following 52-week add-on omalizumab Source: Annual Congress 2013 –Asthma drugs: new findings Year: 2013
An evaluation of the safety, efficacy and cost-effectiveness for patients with acute respiratory illness, of a community-based intravenous medication service: The first 26 months Source: Annual Congress 2011 - The impact of the organisation of care on costs: the role of the physician in home care Year: 2011
The long-term outcomes of a one-year Internet-based self-management support programme compared with usual care in asthma. Additional follow-up 1.5 year after a randomized trial Source: Annual Congress 2010 - Pulmonary rehabilitation and chronic care: new developments in interventions, assessment and care Year: 2010
Impact of add-on medications on patient‘s satisfaction in patients with asthma Source: Eur Respir J 2005; 26: Suppl. 49, 273s Year: 2005
SABINA: global programme to evaluate prescriptions and clinical outcomes related to short-acting ß2 -agonist use in asthma Source: Eur Respir J, 55 (2) 1901858; 10.1183/13993003.01858-2019 Year: 2020
Impact of provider education on the quality of pediatric asthma care: results of a controlled trial Source: Eur Respir J 2004; 24: Suppl. 48, 382s Year: 2004
Randomised control trial to investigate whether electronic adherence monitoring with reminder alarms and feedback can improve clinical outcomes in childhood asthma Source: International Congress 2015 – Paediatric asthma and allergy: e-health in management Year: 2015
Efficacy of a comprehensive education program including inhaler training and COPD management during hospitalization of AECOPD, a randomized controlled clinical Source: International Congress 2018 – Telehealth, home rehabilitation and specific adaptations to exercise interventions in different settings Year: 2018
Single inhaler triple therapy in patients with COPD: patient-reported dyspnoea and health status from the IMPACT Trial Source: International Congress 2018 – Integrating pharmacological and non-pharmacological management in COPD: are we there yet? Year: 2018
Phenotypes related with clinical improvement of omalizumab-treated patients in routine clinical practice. FENOMA Study Source: International Congress 2017 – Techniques to treat asthma Year: 2017
Evaluation of the effectiveness of fax and BlackBerry based symptom diaries for daily monitoring of COPD patients Source: Annual Congress 2008 - Asthma epidemiology Year: 2008
The use of an electronic health record improves asthma clinical outcomes Source: Annual Congress 2010 - Management of airway disease Year: 2010
Cost-benefit and cost-effectiveness analysis of self-management in patients with COPD - a one-year follow-up randomised, controlled trial Source: Eur Respir J 2002; 20: Suppl. 38, 67s Year: 2002
Implementation of questionnaires in the management of asthma patients in clinical practice Source: Annual Congress 2013 –PG18 Assessing the health status and quality of life in asthma and COPD patients Year: 2013
The effect of exacerbation history on outcomes in the IMPACT trial Source: Eur Respir J, 55 (5) 1901921; 10.1183/13993003.01921-2019 Year: 2020
Efficacy and costs of telehealth for the management of COPD: the PROMETE II trial Source: Eur Respir J, 51 (5) 1800354; 10.1183/13993003.00354-2018 Year: 2018
Clinical predictors of the effectiveness of tiotropium in adults with symptomatic asthma: the real-life data Source: International Congress 2018 – Tests and trends in asthma Year: 2018
A multicenter randomized trial for the effectiveness of structured discharge and follow-up protocol on readmission rate in COPD patients receiving LTOT/NIV: one-year interim analysis. Source: International Congress 2018 – Hot topics in non-invasive ventilation Year: 2018